Medicine · Research topic

Open research questions in Electroconvulsive Therapy Studies

202 gap statements mined from Electroconvulsive Therapy Studies papers in our 7.9M-paper local library, which holds 1,120 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Electroconvulsive Therapy Studies? See the ranked Medicine journals.

What the literature leaves open

  • Several limitations of this study should be acknowledged. A key limitation is that biomarker concentrations were assessed at only 1 post-ECT time point, which precludes detection of acute, transient, or time-dependent changes during the course of treatment.

    Changes in Glutathione and Homocysteine Concentrations in Treatment-Resistant Depression After Electroconvulsive Therapy · 2026 · DOI
  • Electroconvulsive therapy (ECT) appears to be well tolerated by older patients with depression; however, it is used rarely in clinical practice and research concerning the oldest-old is lacking.

    Electroconvulsive Therapy in the Oldest-Old Patients With Depression: Response and Remission Rates, Prognostic Factors, Adverse Events and Mortality · 2025 · DOI
  • Depression is common in the oldest-old population (aged ≥85 years), a population in which research is lacking and the effects of psychopharmacological treatment may be adverse.

    Electroconvulsive Therapy in the Oldest-Old Patients With Depression: Response and Remission Rates, Prognostic Factors, Adverse Events and Mortality · 2025 · DOI
  • Repetitive neural stimulations, including electroconvulsive therapy (ECT), effectively treat various psychiatric disorders, but the cellular mechanisms underlying these benefits remain unclear.

    663. REPETITIVE NEURONAL ACTIVATIONS REGULATE CELLULAR MATURATION STATE VIA NUCLEAR REPROGRAMMING · 2025 · DOI
  • Although there are some reports on the actual status of ECT in Japan based on questionnaire surveys, surveys using the National Database are scarce, so a comprehensive survey is needed.

    ELECTROCONVULSIVE THERAPY UTILIZATION IN JAPAN: EPIDEMIOLOGY USING DATA FROM THE NATIONAL DATABASE · 2025 · DOI
  • Given the retrospective design and small sample, these findings should not be interpreted as evidence of validity, prospective reliability, or clinical utility, which remain to be established in prospective studies.

    Clinical Global Impression-Stimulation Outcome Monitoring Tool (CGI-STIM): development and preliminary evaluation of a pragmatic clinical rating tool for electroconvulsive therapy · 2026 · DOI
  • Consequently, the clinical utility of the D-AMI for detecting ECT-associated autobiographical memory changes remains to be established.

    Longitudinal reference data for the German D-AMI in major depression and healthy controls: implications for future ECT research · 2026 · DOI
  • Despite extensive research, the neurobiological mechanisms underlying ECT have not been fully elucidated.

    Effects of Electroconvulsive Therapy on Brain Structure: A Neuroradiological Investigation Into White Matter Hyperintensities, Atrophy, and Microbleeds · 2024 · DOI
  • Electroconvulsive therapy (ECT) induces hippocampal volume alterations, but the clinical significance of the volumetric change remains unclear.

    Electric field strength, hippocampal volume change, and cognitive outcomes following electroconvulsive therapy: the role of sex and anatomy · 2026 · DOI
  • The relationship between ECT and new-onset epilepsy remains controversial based on these findings.

    New Focal Epileptogenesis Following Electroconvulsive Therapy: A Case Report and Literature Review · 2025 · DOI
  • However, its precise mechanism of action in treating catatonia remains to be fully elucidated.

    Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report · 2024 · DOI
  • In recent years, research on the pathogenesis of depression has mostly focused on adult patients, while the pathological mechanism during the critical period of neurodevelopment in adolescence and child remains unclear.

    459. Effects of electroconvulsive therapy on oxidative stress and hippocampal synaptic plasticity in a mouse model of depression in young adolescence · 2026 · DOI
  • There is a need to identify clinical features associated with ECT response in adolescents with MDD. Prior studies have not developed a concise explanatory model that can effectively stratify the risk of poor ECT efficacy.

    Identifying clinical features associated with electroconvulsive therapy response in adolescents with major depressive disorder using machine learning · 2026 · DOI
  • The exact mechanism of ECT remains unclear. There is a need to compare the effects of different anesthetics on seizure duration, hemodynamics, and recovery time in ECT.

    Comparison of the Effects of Dexmedetomidine and Remifentanil on Seizure Duration, Hemodynamics, and Recovery Time in Electroconvulsive Therapy · 2026 · DOI
  • Background and Hypothesis Catatonia is a transdiagnostic syndrome in schizophrenia spectrum disorders (SSD) and mood disorders (MOD), but both its empirical structure and the frequency of its signs and symptoms remain insufficiently understood.

    Dimensional and Network Architecture of Catatonia in Schizophrenia Spectrum Disorders and Mood Disorders: Evidence from a Large, Deeply Phenotyped Sample · 2026 · DOI
  • Electroconvulsive therapy (ECT) is an important treatment for severe, treatment-resistant, or high-risk depression, yet the relationship between its antidepressant effects, brain network changes, and cellular and molecular processes remains incompletely understood.

    Brain Network and Synaptic Plasticity Changes Associated with Electroconvulsive Therapy for Depression: A Multilevel Review · 2026 · DOI
  • Studies have examined ECT, pharmacological, and nonpharmacological relapse prevention strategies, and although current guidelines provide general recommendations, no consensus-based or operationalized guidance exists regarding optimal relapse prevention after successful ECT for major depressive disorder.

    A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive Disorder · 2026 · DOI
  • Observational studies using administrative health data are limited by confounding/bias. There is a need to synthesise evidence from studies utilising administrative health data and modern statistical methods to address clinically relevant questions about ECT's association with dementia, major adverse cardiovascular/cerebrovascular events, suicide deaths, and all-cause mortality.

    Electroconvulsive therapy: improved understanding of long-term risks and benefits from advances in administrative health data · 2026 · DOI
  • While the etiology of his catatonia remains undetermined, his diagnosis of BMD could play a role and further supports the importance of a comprehensive medical work-up.

    A 6-Year-Old With Becker Muscular Dystrophy and Catatonia · 2026 · DOI
  • Also, while one possible hypothesized mechanism in ECT is inflammatory changes, the NODDI parameters produce mixed results in pathologically confirmed neuronal tissue where glia cells are activated.

    Electroconvulsive therapy induces rapid microstructural and macrostructural changes, but microstructural changes are longer-lasting · 2026 · DOI
  • Catatonia is a severe psychomotor syndrome frequently associated with psychotic and mood disorders, and may be under-recognized when overlapping with obsessive-compulsive or neurodevelopmental symptoms.

    404. Hyperactive catatonia in autism and schizoaffective disorder: diagnostic pitfalls and pharmacological insights · 2026 · DOI
  • Conventional catatonia management for stabilization and acute treatment recommends intravenous (IV) or intramuscular (IM) benzodiazepine administration; however, there is relatively limited literature with respect to the safety and efficacy of per os administration.

    Successful Treatment of Catatonia: An Underrepresented Route of Administration Amidst a National Shortage Case Report · 2025 · DOI
  • The use of ketamine in treating treatment-resistant catatonia in patients with schizophrenia has not been described.

    Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report · 2024 · DOI
  • Two open questions, about impact on the patient and on the relative/friend, both elicited about three times as many negative impacts as positive ones.

    An international survey of the relatives and friends of electroconvulsive therapy recipients · 2026 · DOI
  • Hemodynamic instability during ECT. Prolonged recovery time after ECT. Unclear mechanism of ECT.

    Comparison of the Effects of Dexmedetomidine and Remifentanil on Seizure Duration, Hemodynamics, and Recovery Time in Electroconvulsive Therapy · 2026 · DOI

Most-cited papers in Electroconvulsive Therapy Studies

Most recent work

Find a gap in your own Electroconvulsive Therapy Studies sub-topic

This page shows what the Electroconvulsive Therapy Studies literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Open questions raised by papers listed on this page include: (1) Given the retrospective design and small sample, these findings should not be interpreted as evidence of validity, prospective reliability, or clinical utility, which remain to be established in prospective studies (“Clinical Global Impression-Stimulation Outcome Monitoring Tool (CGI-STIM):…”, 2026); (2) The clinical utility of the D-AMI for detecting ECT-associated autobiographical memory changes remains to be established (“Longitudinal reference data for the German D-AMI in major depression and…”, 2026); (3) Electroconvulsive therapy (ECT) induces hippocampal volume alterations, but the clinical significance of the volumetric change remains unclear (“Electric field strength, hippocampal volume change, and cognitive outcomes…”, 2026); (4) In recent years, research on the pathogenesis of depression has mostly focused on adult patients, while the pathological mechanism during the critical period of neurodevelopment in adolescence and child remains unclear (“459. Effects of electroconvulsive therapy on oxidative stress and hippocampal…”, 2026); (5) There is a need to identify clinical features associated with ECT response in adolescents with MDD (“Identifying clinical features associated with electroconvulsive therapy…”, 2026). 202 gap statements have been mined from Electroconvulsive Therapy Studies papers in our 7.9M-paper local library, which holds 1,120 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.